APA (7th ed.) Citation

Ito, Y., Yamada, Y., Asada, K., Ushijima, T., Iwasa, S., Kato, K., . . . Shimada, Y. (2011). Relationship between methylation status of PTEN and point mutation of the EGFR L2 domain and efficacy of cetuximab in metastatic colorectal cancer. Journal of Clinical Oncology, 29(4_suppl), 458. https://doi.org/10.1200/jco.2011.29.4_suppl.458

Chicago Style (17th ed.) Citation

Ito, Y., Y. Yamada, K. Asada, T. Ushijima, S. Iwasa, K. Kato, T. Hamaguchi, and Y. Shimada. "Relationship Between Methylation Status of PTEN and Point Mutation of the EGFR L2 Domain and Efficacy of Cetuximab in Metastatic Colorectal Cancer." Journal of Clinical Oncology 29, no. 4_suppl (2011): 458. https://doi.org/10.1200/jco.2011.29.4_suppl.458.

MLA (9th ed.) Citation

Ito, Y., et al. "Relationship Between Methylation Status of PTEN and Point Mutation of the EGFR L2 Domain and Efficacy of Cetuximab in Metastatic Colorectal Cancer." Journal of Clinical Oncology, vol. 29, no. 4_suppl, 2011, p. 458, https://doi.org/10.1200/jco.2011.29.4_suppl.458.